The decision to treat is based on a belief that the child will be disabled by being extremely<unk>  as an adult, so that the risks of treatment (including sudden death) will outweigh the risks of not treating the symptom of<unk> . Although<unk>  children commonly report being teased about their height, most adults who are very<unk>  are not physically or psychologically disabled by their height. However, there is some evidence to suggest that there is an inverse linear relationship with height and with risk of suicide. Treatment is expensive and requires many years of injections with human growth hormones. The result depends on the cause, but is typically an increase in final height of about taller than predicted. Thus, treatment takes a child who is expected to be much<unk> er than a typical adult and produces an adult who is still obviously<unk> er than average. For example, several years of successful treatment in a girl who is predicted to be as an adult may result in her being instead. Increasing final height in children with<unk>  may be beneficial and could enhance health-related quality of life outcomes, barring troublesome side effects and excessive cost of treatments. Cost The cost of treatment depends on the amount of growth hormone given, which in turn depends on the child's weight and age. One year's worth of drugs normally costs about US$20,000 for a small child and over $50,000 for a teenager. These drugs are normally taken for five or more years.
Short stature
Adipomastia
Stunted growth
Failure to thrive
Hyperdontia
Trichomegaly
Anisomastia
Muscle dysmorphia